CD95 (Fas)1 is a type I transmembrane protein expressed by a variety of nucleated cells (1). The physiological ligand for Fas (FasL) is a type II transmembrane protein expressed by activated T cells and non-T cells under a variety of conditions (2-11). Cross-linking of Fas induces cells to undergo apoptosis (12)(13)(14). This apoptosis pathway has been implicated in immune response regulation, self-tolerance, graft rejection, tumor escape of immune surveillance, and maintenance of the immune privileged sites (2-6, 15-28).Regulation of FasL expression has been demonstrated at the transcriptional and post-transcriptional levels (4 -6, 29 -32).Recent studies have suggested that the level of cell surface FasL is regulated by a mechanism involving matrix metalloproteinase (MMP) cleavage that releases from cells soluble FasL (sFasL) lacking the transmembrane and cytoplasmic domains (29 -32). Compared with cell-associated FasL, sFasL is a relatively poor mediator of cytotoxicity. Indeed, under certain conditions, sFasL can actually inhibit the cytotoxicity of FasLexpressing cells (30, 31). Thus, sFasL release effectively downregulates the function of cell-associated FasL. Here, we demonstrate that there is a second mechanism responsible for FasL turnover. This mechanism involves the release of cell surface FasL in the form of vesicles, which contain full-length FasL and are bioactive. Although the presence of FasL-bearing vesicles was implicated in previous studies (33, 34), the FasL expression level was so low that a quantitative study to determine its contribution to cell membrane FasL turnover was difficult. We have generated retroviral packaging cell lines that produce large amounts of FasL-expressing vesicles; however, it is not clear whether the retroviral packaging process has influenced the production of FasL membrane vesicles (35-37).To determine whether normal FasL-expressing cells produce apoptosis-inducing vesicles, we generated FasL-expressing 3T3 cells that do not produce virus. We generated T cells that produce high levels of membrane FasL upon activation. In addition, we studied normal T cells for cell membrane FasL turnover upon activation. We demonstrated that these cells release of FasL-bearing vesicles capable of inducing apoptosis in target cells. Our quantitative analysis indicated that release of vesicles contributes to the turnover of cell-associated FasL, but the extent of contribution varies in different cell lines examined. Interestingly, the apoptosis-inducing vesicles display unique properties. In contrast to sFasL, FasL-bearing vesicles fully retained the target range of the FasL-expressing cells. However, there is a reduction of specific activity in comparison with cell-associated FasL. These observations suggest that release of vesicles is a physiologically significant process regarding both the turnover of cell-associated FasL and the impact on FasL function of the FasL-expressing cells.
EXPERIMENTAL PROCEDURESProduction of FasL-expressing Cell Lines-We obtained an hfasl cDNA construct ...